


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+5.41%
+0.27%
+0.81%
+3.85%
ENGN
enGene Holdings Inc.
$7.26
Strengths

Upgraded on attractively valued

Outperform the market
Risk Analysis

Earnings are forecast to decrease
Chart
$7.91 (-8.22%)
$4.62 (+57.14%)
$4.34 (+67.28%)
$4.34 (+67.28%)
ENGN has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

High volatilty

ENGN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to decrease

Outperform the market
![]()
ENGN Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ENGN Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is ENGN current stock price?
What are ENGN stock strengths?
What is ENGN Risk Level?
What is ENGN market cap and volume?
What is ENGN current Stock IQ?
Should I buy ENGN stock right now?
Is ENGN a Strong Buy right now?
What does a 'Strong Buy' rating mean for ENGN?
What does a 'Strong Sell' rating mean for ENGN?
What factors influence ENGN's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+5.41%
+0.27%
+0.81%
+3.85%
ENGN
enGene Holdings Inc.
Current Price
$7.26
Stock Insights
Strengths

Upgraded on attractively valued

Outperform the market
Risk Analysis

Earnings are forecast to decrease

Chart
$7.91 (-8.22%)
$4.62 (+57.14%)
$4.34 (+67.28%)
$4.34 (+67.28%)
ENGN Analysts Opinion
ENGN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to decrease

Outperform the market
![]()
ENGN Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ENGN Street Sentiment is bullish and have positive views on the near-term outlook
ENGN has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

High volatilty

Average key support and resistance price levels.
ENGN Latest Analysis
enGene Holdings (ENGN) Price Target Increased by 10.59% to 24.20. The average one-year price target for enGene Holdings (NasdaqCM:ENGN) has been revised to $24.20 / share. This is an increase of 10.59% from the prior estimate of $21.88 dated November 7 2025. The price target is an average of many targets provided by analyst
Mon Nov 17, 2025
enGene Holdings Inc. (ENGN) Discusses Preliminary Data From LEGEND Pivotal Cohort in High-Risk BCG-Unresponsive NMIBC - Slideshow.
Fri Nov 14, 2025
Oppenheimer Reiterates enGene Holdings (ENGN) Outperform Recommendation. Fintel reports that on November 12 2025 Oppenheimer reiterated coverage of enGene Holdings (NasdaqCM:ENGN) with a Outperform recommendation. Analyst Price Forecast Suggests 152.99% Upside
Thu Nov 13, 2025
Morgan Stanley Maintains enGene Holdings (ENGN) Overweight Recommendation. Fintel reports that on November 12 2025 Morgan Stanley maintained coverage of enGene Holdings (NasdaqCM:ENGN) with a Overweight recommendation. Analyst Price Forecast Suggests 152.99% Upside
Thu Nov 13, 2025
Citizens Maintains enGene Holdings (ENGN) Market Outperform Recommendation. Fintel reports that on November 12 2025 Citizens maintained coverage of enGene Holdings (NasdaqCM:ENGN) with a Market Outperform recommendation. Analyst Price Forecast Suggests 152.99% Upside
Thu Nov 13, 2025
UBS Maintains enGene Holdings (ENGN) Neutral Recommendation. Fintel reports that on November 12 2025 UBS maintained coverage of enGene Holdings (NasdaqCM:ENGN) with a Neutral recommendation. Analyst Price Forecast Suggests 152.99% Upside
Thu Nov 13, 2025
enGene Holdings: Still A Buy After A Massive Surge.
Wed Nov 12, 2025
enGene Holdings Inc. (ENGN) Discusses Preliminary Data From LEGEND Pivotal Cohort in High-Risk BCG-Unresponsive NMIBC Transcript.
Tue Nov 11, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ENGN Stock trends
ENGN Stock performance
ENGN Stock analysis
ENGN investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.